Archives: Seminars

Each Country has taken different approaches to fix the same problem – why is this? Why is harm reduction a recognised tool for many societal issues, but so controversial in tobacco control? We recognize and protect public health policy discussions from conflicts of interest with tobacco industry but is there a conflict of interest with… Read more »

Research over the past decade has provided evidence for the potential of harm reduction from e-cigarettes, but there are considerable challenges along the path from potential to reality, of which a key component is the extent to which e-cigarettes can help smokers quit. Clinical trials have demonstrated the efficacy of e-cigarettes as a cessation aid,… Read more »

The status of reduced-risk products in a smokefree society In Norway has meant that practically no one initiates cigarette smoking any longer. The prevalence of daily smoking in the age-group 16-24 years has dropped below the 2% mark. The remaining smokers are typically in their 60’s. Within few decades Norway will probably be almost smokefree,… Read more »

Aotearoa New Zealand’s government has tabled some of the world’s most aggressive tobacco control policy with an explicit focus on smoked tobacco. Endgame legislation proposes to remove nicotine from all smoked tobacco, drastically reduce supply by 95%, and ban the sale of smoked tobacco to anyone born after January 2009. The aim being to reduce… Read more »

Mr. Zeller will share his views on the evolution of the harm reduction debate in the United States, where for nearly 30 years he has played a central role.  He will talk about the process of achieving consensus around harm reduction and the continuum of risk in the 2005-2009 Strategic Dialogue on Tobacco Harm Reduction,… Read more »

Deborah Arnott will set out how the UK government’s approach to e-cigarettes is misunderstood and overstated both by those who support and oppose the role of these products in helping bring about the end of smoking. She will make a plea for both sides to recognise that the UK government positions harm reduction in tobacco… Read more »

To paraphrase the Cheshire Cat in Alice in Wonderland, “if you don’t know where you are going, any road will take you there”. Are we thrashing about doing the wrong things in public health and tobacco control because we have wrong or outdated models of the phenomena we are dealing with? Many professionally engaged in tobacco… Read more »

Back in 2013, the disposable e-cigarette was a product type that many of us thought to be in its early death throes.  Advocates and the independent industry alike were certain that it would all be about refillable, reusable and rechargeable open systems from there on in.  We can track the re-birth, understanding the market forces… Read more »

A medicinally-authorized e-cigarette has been a topic of discussion since before the first Summit in 2013.  There were those who argued that only medicinally-licensed e-cigarettes should be on the market, while others believed that a medicinal-only marketplace would be accessible only for the big tobacco companies – who arguably had the least incentive to lead… Read more »

Policies to shift the market for nicotine from cigarettes to non-combustibles (as, for example, the mooted FDA proposal to reduce the absolute bioavailability of nicotine from cigarettes to non-reinforcing levels) have as an essential component the development of consumer-acceptable alternative novel nicotine products. Regulators may seek to set limits for the nicotine dose available from… Read more »